United Imaging announces global commercialization of "video-capable" uMR Ultra 3T MRI, secured by approvals from China, US, and Europe

On September 29, United Imaging's new 3T MRI system, uMR Ultra, received market approval from China's National Medical Products Administration (NMPA). The system has also obtained U.S. FDA clearance and European CE certification, achieving global commercial availability.

As the world's first "video-capable" MRI system, uMR Ultra incorporates the industry's pioneering LIVE Imaging technology, revolutionizing the paradigm from "still photography" to "real-time videography."

What distinguishes it from conventional systems? While traditional MRI generates sequences of static images—capturing anatomical structures within specific timeframes—it remains vulnerable to motion artifacts that compromise diagnostic clarity. This limitation stems from the technology's high sensitivity to physiological movements: inevitable motion during scanning (e.g., respiration, cardiac activity, peristalsis) introduces blurring, ghosting, or streaking artifacts that degrade image quality and can obscure pathology.

In contrast, uMR Ultra integrates a next-generation AI imaging chain that leverages the synergy between ultra-high-performance gradient systems and a spatiotemporal AI engine. This enables continuous capture of high-definition dynamic images of both anatomy and functional tissue activity. The system shows significant potential for observing, diagnosing, and researching moving structures and is poised to provide unprecedented insights for evaluating the gastrointestinal tract, pelvic region, joints, and nervous system—ultimately driving comprehensive innovation in clinical standards.

A clinical neuroscience research program centered on this system was recently launched at Huashan Hospital, Fudan University. The initiative will leverage the platform to establish standardized applications for dynamic imaging technology—with a neurology focus and driven by clinical needs—while advancing cutting-edge research on major diseases. The program aims to propel medical imaging into a new phase of development.